MAIA Biotechnology, Inc. (MAIA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-942.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | — |
| Operating Income | -$24.27M | -$16.96M | -$20.18M | -$16.18M | -$7.79M |
| Net Income | -$22.40M | -$23.25M | — | — | — |
| EPS (Diluted) | $-0.70 | $-1.05 | $-1.49 | $-1.75 | $-2.37 |
| Total Assets | $9.70M | $10.16M | $7.57M | $12.02M | $11.33M |
| Total Liabilities | $7.33M | $6.52M | $7.09M | $3.51M | $2.15M |
| Shareholders' Equity | $2.38M | $3.63M | $477.5K | — | — |
| Cash & Equivalents | $0 | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$18.84M | -$15.70M | -$13.07M | -$12.10M | -$4.12M |
| Shares Outstanding | 38.62M | 26.16M | 16.99M | 10.96M | 7.58M |